AbbVie (ABBV) News Today → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free ABBV Stock Alerts $164.62 -1.80 (-1.08%) (As of 05/20/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 20 at 8:17 PM | marketbeat.comFranklin Resources Inc. Grows Stock Position in AbbVie Inc. (NYSE:ABBV)Franklin Resources Inc. increased its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 4.7% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,570,685 shares of the company's stock after purchasing an additional 338,789 sharMay 20 at 3:30 PM | marketbeat.comAbbVie (NYSE:ABBV) Trading Down 0.3%AbbVie (NYSE:ABBV) Shares Down 0.3%May 20 at 2:47 PM | investorplace.com3 S&P 500 Stocks That Have Proven Themselves Recession-ProofMay 20 at 10:58 AM | fool.com1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?May 19 at 11:24 PM | marketbeat.comCornerstone Advisors LLC Reduces Position in AbbVie Inc. (NYSE:ABBV)Cornerstone Advisors LLC lowered its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 7.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 79,700 shares of the company's stock after selling 6,300 sharMay 19 at 6:45 PM | marketbeat.comKentucky Retirement Systems Acquires 6,000 Shares of AbbVie Inc. (NYSE:ABBV)Kentucky Retirement Systems lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 4.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 141,262 shares of the company's stock after purchasing an additionalMay 19 at 4:58 AM | americanbankingnews.comAbbVie (NYSE:ABBV) Shares Up 0.5%May 19 at 3:26 AM | americanbankingnews.comAbbVie (NYSE:ABBV) Earns Overweight Rating from Analysts at Cantor FitzgeraldMay 18 at 11:22 PM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Position Boosted by Mizuho Markets Americas LLCMizuho Markets Americas LLC increased its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 33.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,914 shares of the company's stock after buyingMay 18 at 12:22 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Sold by Princeton Capital Management LLCPrinceton Capital Management LLC decreased its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 68.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,267 shares of the company's stock aftMay 17, 2024 | msn.comCantor Fitzgerald Initiates Coverage of AbbVie (ABBV) with Overweight RecommendationMay 17, 2024 | msn.comAbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': AnalystMay 17, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Trading 0.5% Higher AbbVie (NYSE:ABBV) Trading 0.5% HigherMay 17, 2024 | markets.businessinsider.comThe Analyst Verdict: AbbVie In The Eyes Of 5 ExpertsMay 17, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Coverage Initiated at Cantor FitzgeraldCantor Fitzgerald began coverage on AbbVie in a research report on Friday. They issued an "overweight" rating and a $200.00 price objective for the company.May 17, 2024 | prnewswire.comAbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®May 17, 2024 | investorplace.com7 Value Stocks to Buy and Hold for a Decade of DominanceMay 17, 2024 | marketbeat.comAbbVie Q1 Earnings TranscriptMay 17, 2024 | americanbankingnews.comZacks Research Weighs in on AbbVie Inc.'s FY2024 Earnings (NYSE:ABBV)May 16, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Stock Price Down 0.8%AbbVie (NYSE:ABBV) Stock Price Down 0.8%May 16, 2024 | marketbeat.comAbbVie Inc. (NYSE:ABBV) Short Interest UpdateAbbVie Inc. (NYSE:ABBV - Get Free Report) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 14,480,000 shares, an increase of 6.9% from the April 15th total of 13,540,000 shares. Based on an average daily volume of 5,670,000 shares, the short-interest ratio is presently 2.6 days. Approximately 0.8% of the shares of the company are sold short.May 16, 2024 | msn.comAbbVie makes psychedelic play with $2bn Gilgamesh collaborationMay 16, 2024 | marketbeat.comFY2024 EPS Estimates for AbbVie Inc. Lifted by Analyst (NYSE:ABBV)AbbVie Inc. (NYSE:ABBV - Free Report) - Research analysts at Zacks Research increased their FY2024 earnings per share (EPS) estimates for AbbVie in a note issued to investors on Tuesday, May 14th. Zacks Research analyst S. Ganoria now anticipates that the company will post earnings of $11.21 perMay 16, 2024 | investorplace.comWall Street Favorites: 3 Retirement Stocks With Strong Buy Ratings for May 2024May 16, 2024 | americanbankingnews.comAbbVie Inc. (NYSE:ABBV) to Post Q2 2024 Earnings of $3.01 Per Share, Zacks Research ForecastsMay 15, 2024 | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Sold by Janney Capital Management LLCJanney Capital Management LLC trimmed its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 17.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 119,062 shares of the company's stock after selling 24,946 shares duMay 15, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Stock Price Up 0.9%AbbVie (NYSE:ABBV) Stock Price Up 0.9%May 15, 2024 | benzinga.comUnpacking the Latest Options Trading Trends in AbbVieMay 15, 2024 | seekingalpha.comAbbVie, Inc. (ABBV) Bank of America Health Care Conference Call TranscriptMay 15, 2024 | marketbeat.comZacks Research Research Analysts Lift Earnings Estimates for AbbVie Inc. (NYSE:ABBV)AbbVie Inc. (NYSE:ABBV - Free Report) - Zacks Research upped their Q2 2024 earnings per share (EPS) estimates for AbbVie in a research report issued on Tuesday, May 14th. Zacks Research analyst S. Ganoria now expects that the company will earn $3.01 per share for the quarter, up from their previoMay 15, 2024 | marketbeat.comMinichMacGregor Wealth Management LLC Has $246,000 Holdings in AbbVie Inc. (NYSE:ABBV)MinichMacGregor Wealth Management LLC decreased its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 94.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,586 shares of the company's stock after selling 24,656 shMay 14, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Shares Down 0.2% AbbVie (NYSE:ABBV) Shares Down 0.2%May 14, 2024 | businesswire.comAlzamend Neuro Announces Initial Closing of Private PlacementMay 14, 2024 | fool.com3 Magnificent Stocks That Are Passive Income MachinesMay 13, 2024 | marketbeat.comBoston Partners Decreases Stock Holdings in AbbVie Inc. (NYSE:ABBV)Boston Partners reduced its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 7.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,202,814 shares of the company's stock after selling 93,821 shares durinMay 13, 2024 | markets.businessinsider.comAbbVie To Collaborate With Gilgamesh To Develop Next-Gen Psychiatric TherapiesMay 13, 2024 | msn.comAbbVie, Gilgamesh to develop next-generation psychedelic drugsMay 13, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Trading Up 0.7%AbbVie (NYSE:ABBV) Trading 0.7% HigherMay 13, 2024 | fool.comWhat Is the Dividend Payout for AbbVie Stock?May 13, 2024 | prnewswire.comAbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric DisordersMay 12, 2024 | marketbeat.comKing Wealth Management Group Purchases 5,038 Shares of AbbVie Inc. (NYSE:ABBV)King Wealth Management Group grew its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 189.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,701 shares of the company's stock after purchasingMay 12, 2024 | americanbankingnews.comAbbVie (NYSE:ABBV) Trading Up 0.1%May 11, 2024 | marketbeat.comSP Asset Management LLC Has $35.58 Million Stake in AbbVie Inc. (NYSE:ABBV)SP Asset Management LLC grew its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 3.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 229,563 shares of the company's stock after acquiring an additioMay 11, 2024 | businesswire.comLANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABPMay 11, 2024 | fool.comWant Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.May 10, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Shares Up 0.1%AbbVie (NYSE:ABBV) Stock Price Up 0.1%May 10, 2024 | marketbeat.comUS Asset Management LLC Takes $1.05 Million Position in AbbVie Inc. (NYSE:ABBV)US Asset Management LLC purchased a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 6,744 shares of the company's stock, valued at appMay 10, 2024 | fool.com3 Rock-Solid Dividend Stocks That Are Ideal for RetireesMay 9, 2024 | marketbeat.comBreed s Hill Capital LLC Invests $1.18 Million in AbbVie Inc. (NYSE:ABBV)Breed s Hill Capital LLC purchased a new position in AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 7,642 shares of the company's stock, valued at apprMay 9, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Stock Price Up 0.5%AbbVie (NYSE:ABBV) Stock Price Up 0.5% Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address What President Biden's new law means for investors (Ad)What's Got Musk, Bezos, and Gates So Excited? Billionaires are plowing millions of dollars into a new technology that early estimates say could generate more wealth than A.I. – and determine the future of companies like Microsoft. The problem? Most investors have no idea it's happening, or how to profit on it. This expert just went public with all the details, including which stocks to jump on immediately. ABBV Media Mentions By Week ABBV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABBV News Sentiment▼0.590.42▲Average Medical News Sentiment ABBV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABBV Articles This Week▼4323▲ABBV Articles Average Week Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MRK News Today JNJ News Today PFE News Today BMY News Today ZTS News Today MRNA News Today IDXX News Today SGEN News Today IQV News Today BNTX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABBV) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Crypto for AIWeiss RatingsWarren Buffett's "mystery stock"Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
